Retatrutide clinical trial results The retatrutide data comes from the Phase 2 trial published in the New England Journal of Medicine and the ongoing Phase 3 TRIUMPH program
Long-Term Side Effects of GLP-1 Medications Research into the long-term effects of GLP-1 medications is ongoing
At Wellness Solutions, we believe true wellness starts from within, and were proud to offer carefully selected products that align with our philosophy of elevated, intentional care
Dermatologists use depigmenting creams with various active ingredients in the treatment of melasma and post-inflammatory hyper-pigmentation
After 36 weeks, the placebo group had lost an average of 2.3%, or 5.3 pounds, compared to 9.4% to 14.7%, or 21.6 to 34 pounds, in the orforglipron groups
For too long, issues with the cervix like cervical insufficiency and preterm birth have posed serious challenges